Resistance to TRAIL-induced apoptosis caused by constitutional phosphorylation of Akt and PTEN in acute lymphoblastic leukemia cells

Experimental Hematology

Volumn 36, Issue 10, 2008, Pages 1343-1353

  Dida, Francis ^a   Li, Yufeng ^a   Iwao, Atsushi ^a   Deguchi, Takao ^a   Azuma, Eiichi ^a   Komada, Yoshihiro ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; CASPASE 8; FLICE INHIBITORY PROTEIN; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; OKADAIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROPIDIUM IODIDE; PROTEIN BID; PROTEIN KINASE B; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CHROMOSOME 10; CONTROLLED STUDY; CYTOGENETICS; DOWN REGULATION; DRUG DOSE INCREASE; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LOW DRUG DOSE; LYMPHATIC LEUKEMIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANTIGENS, CD; APOPTOSIS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; MICROSCOPY, CONFOCAL; PHOSPHORYLATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 52049088263     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.04.011     Document Type: Article

References (25)

1. Wiley S.R., Schooley K., Smolak P.J., et al. Identification and characterization of a new member of TNF family that induces apoptosis. Immunity 3 (1995) 673-682
2. Walczak H., Miller R.E., Ariail K., et al. Tumoricidal activity of tumor necrosis factor-related apoptosis inducing ligand in vivo. Nat Med 5 (1999) 157-163
3. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305-1308
4. Mitsiades N., Mitsiades C.S., Poulaki V., Anderson K.C., and Treon S.P. Intracellular regulation of tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis in human multiple myeloma cells. Blood 99 (2002) 2162-2171
5. Pan G., Ni J., Wei Y.F., Yu G., Gentz R., and Dixit V.M. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277 (1997) 815-818
6. Pan G., Ni J., Yu G., Wei Y.F., and Dixit V.M. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signaling. FEBS Lett 424 (1998) 41-45
7. Chen X., Thakkar H., Tyan F., et al. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer. Oncogene 20 (2001) 6073-6083
8. Brognard J., Clark A.S., Ni Y., and Dennis P.A. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer 61 (2001) 3986-3997
9. Dutton A., Reynolds G.M., Dawson C.W., Young L.S., and Murray P.G. Constitutive activation of phosphotidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR. J Pathol 205 (2005) 498-506
10. Vivanco I., and Sawyers C.L. The phosphatidylinositol 3-kinase Akt pathway in human cancer. Nat Rev Cancer 2 (2002) 489-501
11. Luo J., Manning B.D., and Cantley L.C. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4 (2003) 257-262
12. Miller S.J., Lou D.Y., Seldin C., Lane W.S., and Neel B.G. Direct identification of PTEN phosphorylation sites. FEBS Lett 528 (2002) 145-153
13. Mills G.B., Lu Y., Fang X., Wang H., Eder A., and Mao M. The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy. Semin Oncol 28 (2001) 125-141
14. Gao T., Furnari F., and Newton A.C. PHLLP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 18 (2005) 13-24
15. Cheng J., Hylander B.L., Baer M.R., Chen X., and Repasky E.A. Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL. Mol Cancer Ther 5 (2006) 1844-1853
16. MacFarlane M., Harper N., Snowden R.T., Dyer M.J., Barnett G.A., and Pringle J.H. Mechanisms of resistant to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukemia. Oncogene 21 (2002) 6809-6818
17. Hao X.-S., Hao J.-H., Liu F.-T., Newland A.C., and Jia L. Potential mechanisms of leukemia cell resistance to TRAIL-induced apoptosis. Apoptosis 8 (2003) 601-607
18. Secchiero P., Grazia Di Iasio M., Gonelli A., et al. Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70. Cell Physiol 213 (2007) 229-236
19. Colo G.P., Rubio M.F., Alvarado C.V., and Costas M.A. Medicina (B Aires) 67 (2007) 465-468
20. Kandel E.S., and Hay N. The regulation of activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 253 (1999) 210-229
21. Xu Q., Simpson S.E., Scialla T.J., Bagg A., and Carrol M. Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood 102 (2003) 972-980
22. Gong B., and Amasan A. Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptosis signaling induced by ionizing radiation in leukemic cells. Cancer Res 60 (2000) 5754-5760
23. Kang J., Kisenge R., Toyoda H., Azuma E., and Komada Y. Chemical sensitization and regulation of TRAIL-induced apoptosis in a panel of B-lymphocytic leukemia cell lines. Br J Hematol 123 (2003) 921-932
24. Cai Z., and Semeza G.L. PTEN activity is modulated during ischemia and reperfusion. Circ Res 97 (2005) 1351-1359
25. Matsuo Y., Ariyasu T., Adachi T., Tsubota T., and Minowada J. Two t(9;22) leukemia cell lines (NALM-24 and NALM-25) with biphenotypic characteristics and an EBV-positive B-cell non-leukemia cell line (B262) established from a patient with acute lymphoblastic leukemia. Human Cell 4 (1991) 339-342